Multiple Assemblies exist for SMTL entry 6ylc
Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors; X-RAY DIFFRACTION 2.43 Å

	SMTL ID 6ylc.1 Ligands 5-fluoranyl-2-[5-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]benzenecarbonitrile Polypeptides Mitogen-activated protein kinase 6 Oligo-state monomer
	SMTL ID 6ylc.2 Ligands 5-fluoranyl-2-[5-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]benzenecarbonitrile Polypeptides Mitogen-activated protein kinase 6 Oligo-state monomer
	SMTL ID 6ylc.3 Ligands 5-fluoranyl-2-[5-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]benzenecarbonitrile Polypeptides Mitogen-activated protein kinase 6 Oligo-state monomer
	SMTL ID 6ylc.4 Ligands 5-fluoranyl-2-[5-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]benzenecarbonitrile Polypeptides Mitogen-activated protein kinase 6 Oligo-state monomer